Hence, we examined the effect of erastin on the tumorigenicity of BC cells BT-474T, a variant of ErbB2/Her2-positive human BC cells BT-474 selected for increased tumorigenic capacity in immunodeficient mice [3]. This evidence concerns the gene ERBB2 and breast cancer.